Quality vaccines for all people. Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.

Vaccine

Volumn 34, Issue 31, 2016, Pages 3562-3567

  Pagliusi, Sonia ^a   Ting, Ching Chia ^a   Khomvilai, Sumana ^b   Homma, Akira ^c   Meng, Li ^c   Suhardono, Mahendra ^c   Tippoo, Patrick ^c   Jadhav, Suresh ^c   Gao, Steven ^c   Prasad, Ray ^c   Suri, Rajinder K ^c   Thai, Pan Hong ^c   Vonghangoola, Vitoon ^c  

^a DCVMN International   (Switzerland)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c NONE

Author keywords

Developing countries; Immunisation; Quality; Technology innovation; Vaccine markets

Indexed keywords

CHOLERA VACCINE; DENGUE VACCINE; INFLUENZA VACCINE; VACCINE; WART VIRUS VACCINE;

CHEMOPROPHYLAXIS; CHIKUNGUNYA; CLINICAL DECISION MAKING; CONFERENCE PAPER; DEVELOPING COUNTRY; DRUG MARKETING; DRUG QUALITY; HUMAN; IMMUNIZATION; MULTICENTER STUDY (TOPIC); PRIORITY JOURNAL; THAILAND; VACCINE PRODUCTION; COMMUNICABLE DISEASE CONTROL; DECISION MAKING; ECONOMICS; GLOBAL HEALTH; INTERNATIONAL COOPERATION; MEDICAL TECHNOLOGY; ORGANIZATION; SUPPLY AND DISTRIBUTION; TECHNOLOGY;

BIOMEDICAL TECHNOLOGY; COMMUNICABLE DISEASE CONTROL; CONGRESSES AS TOPIC; DECISION MAKING; DEVELOPING COUNTRIES; GLOBAL HEALTH; HUMANS; INTERNATIONAL COOPERATION; TECHNOLOGY TRANSFER; THAILAND; VACCINES;

EID: 84961226931     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.02.067     Document Type: Conference Paper

References (26)

1. Measles WHO fact sheet 286 2015, Updated November 2015. Available at: 〈http://www.who.int/mediacentre/factsheets/fs286/en/〉.
2. Novak R.T., Kambou J.L., Diomandé F.V., Tarbangdo T.F., Ouédraogo-Traoré R., Sangaré L., et al. meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infect Dis 2012, 12(10):757-764.
3. GAVI Alliance sets out opportunity to save up to six million lives through immunization. Gavi PR of 20 May 2014. Available at: 〈http://www.gavi.org/Library/News/Press-releases/2014/GAVI-Alliance-sets-out-opportunity-to-save-up-to-six-million-lives-through-immunisation/〉.
4. Media centre of World Health Organisation Immunization leaders call for increased political support for immunization in Pakistan 2015, Media centre of World Health Organisation, Available at: 〈http://www.emro.who.int/media/news/political-support-immunization-pakistan.html〉.
5. Meningitis vaccine project. Eliminating epidemic meningitis as a public health problem in sub-Saharan Africa. A public health breakthough. Available at: 〈http://www.meningvax.org/〉.
6. Association of Southeast Asian Nations. Asean Member States. Available at: 〈http://www.asean.org/asean/about-asean〉.
7. Wechsler J. Regulatory convergence sought for global pharma market. BioPharm Int 2013, 26(5). Available at: 〈http://www.biopharminternational.com/regulatory-convergence-sought-global-pharma-market-0?id=&pageID=1&sk=&date=〉.
8. Gavi, The Vaccine Alliance. About Gavi. Gavi's business model: working together for healthy vaccine markets. Available at: 〈http://www.gavi.org/about/gavis-business-model/making-vaccines-affordable/〉.
9. The Yellow Fever Initiative: providing an opportunity for a lifetime. 2010. WHO-UNICEF Brochure. Available at: 〈http://www.who.int/csr/disease/yellowfev/YFIbrochure.pdf〉.
10. Saha A., Chowdhury M.I., Khanam F., Bhuiyan M.S., Chowdhury F., Khan A.I., et al. Safety and immunogenicity study of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, ShanChol, in Bangladeshi adults and young children as young as 1 year of age. Vaccine 2011, 29(46):8285-8292.
11. Bhan M.K., Glass R.I., Ella K.M., Bhandari N., Boslego J., Greenberg H.B., et al. Team science and the creation of a novel rotavirus vaccine in India: a new framework for vaccine development. Lancet 2014, 383(9935):2180-2183.
12. Precioso A.R., Palacios R., Thomé B., Mondini G., Braga P., Kalil J. Clinical evaluation strategies for a live attenuated tetravalent dengue vaccine. Vaccine 2015, 33(50):7121-7125.
13. Buasri W., Impoolsup A., Boonchird C., Luengchaichawange A., Prompiboon P., Petre J., et al. Construction of Bordetella pertussis strains with enhanced production of genetically-inactivated pertussis Toxin and Pertactin by unmarked allelic exchange. BMC Microbiol 2012, 12:61.
14. Gavillet B.M., Mondoulet L., Dhelft V., Eberhardt C.S., Auderset F., Pham H.T., et al. Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: preclinical proof of concept. Vaccine 2015, 33(30):3450-3455.
15. Pagliusi S., Jain R., Suri R.K. Vaccines, our shared responsibility. Vaccine 2015, 33(19):2197-2202. DCVMN Executive Committee Group.
16. Benevolo-de-Andrade T.C., Monteiro-Maia R., Cosgrove C., Castello-Branco L.R. BCG Moreau Rio de Janeiro: an oral vaccine against tuberculosis-review. Mem Inst Oswaldo Cruz 2005, 100(5):459-465.
17. Gomes L.H.F., Otto T.D., Vasconcellos E.A., et al. Genome Sequence of Mycobacterium bovis BCG Moreau, the Brazilian Vaccine Strain against Tuberculosis. J Bacteriol 2011, 193(19):5600-5601.
18. Gan C., Mostafid H., Khan M.S., Lewis D.J.M. BCG immunotherapy for bladder cancer-the effects of substrain differences. Nat Rev Urol 2013, 10(10):580-588.
19. Liao G., Li R., Li C., Sun M., Li Y., Chu J., et al. Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: a phase II, randomized, positive-controlled trial. J Infect Dis 2012, 205(2):237-243.
20. Weaver S.C., Osorio J.E., Livengood J.A., Chen R., Stinchcomb D.T. Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines 2012, 11(9):1087-1101.
21. Hotez P, The disease next door. Foreign policy 2013. Available at 〈http://foreignpolicy.com/2013/03/25/the-disease-next-door/〉.
22. Baik Y.O., Choi S.K., Olveda R.M., Espos R.A., Ligsay A.D., Montellano M.B., et al. A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines. Vaccine 2015, 33(46):6360-6365.
23. Martin S., Costa A., Perea W. Stockpiling oral cholera vaccine. Bull World Health Organ 2012, 90(10):714.
24. Hepatitis E vaccine: WHO position paper, May 2015. Wkly Epidemiol Rec 2015;90(18):185-200.
25. Nyenswah T.G., Kateh F., Bawo L., Massaquoi M., Gbanyan M., Fallah M., et al. Ebola and its control in Liberia, 2014-2015. Emerg Infect Dis 2016, 22(2):169-177.
26. Evaluate Pharma Report. 8th edition, June 2015. World preview2015: outlook to 2020. Vaccines Market to 2020. Available at 〈http://info.evaluategroup.com/rs/607-YGS-364/images/wp15.pdf〉, pp. 37-38.